European Medicines Agency

The European Medicines Agency (EMA) is aiming to approve the Covid-19 vaccine developed by Pfizer and BioNTech on December 23, German newspaper Bild reported on Tuesday, citing government and European Commission sources.

Documents related to the Pfizer coronavirus vaccine were illegally accessed during a cyberattack at the EU regulator, the company said on Dec. 9, as Germany and other northern hemisphere countries grappled with a winter surge in the pandemic.

Britain's medicine regulator has advised that people with a history of significant allergies do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported severe adverse reactions on the first day of rollout.

The European Union's healthcare regulator said that no drug shortages or supply disruptions have been reported in the region but that an EU steering group had convened to prevent supply bottlenecks due to the coronavirus outbreak.

"As the public health emergency develops, shortages or disruptions cannot be excluded," the European Medicines Agency (EMA) said in a statement on Tuesday.